RecruitingNCT06244433

Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome

Risk Stratification of Sudden Unexpected Death in Infant Based on Biomarkers - Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome


Sponsor

Nantes University Hospital

Enrollment

650 participants

Start Date

Aug 27, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This is a multicenter genetic study aimed at identifying new genes/variants associated with sudden infant death syndrome (SIDS) based on whole-genome sequencing of family trios


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying whole genome sequencing for people with sudden infant death and sudden unexplained infant death. The study is currently recruiting participants at 18 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICwhole genome sequencing

Study of all coding and non-coding sequences in the genome to identify pathogenic allelic variants


Locations(18)

Nantes University Hospital

Nantes, Loire-Atlantique, France

CHU Amiens

Amiens, France

CHU Angers

Angers, France

CHU Besançon

Besançon, France

APHP - Hôpital Jean Verdier

Bondy, France

CHU Brest

Brest, France

CHU de Caen-Normandie

Caen, France

APHP - Hôpital Antoine Béclère

Clamart, France

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, France

CHU Grenoble

Grenoble, France

HCL

Lyon, France

AP-HM

Marseille, France

CHU Montpellier

Montpellier, France

CHRU Nancy

Nancy, France

CHU de Poitiers

Poitiers, France

CHU Rouen

Rouen, France

CHU Saint Etienne

Saint-Etienne, France

CHU Toulouse

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06244433


Related Trials